07:38:14 EDT Tue 14 May 2024
Enter Symbol
or Name
USA
CA



Titan Medical Inc (2)
Symbol TMD
Shares Issued 113,528,260
Close 2023-10-17 C$ 0.14
Market Cap C$ 15,893,956
Recent Sedar Documents

Titan Medical changes auditor to MNP

2023-10-18 14:08 ET - News Release

Mr. Chien Huang reports

TITAN MEDICAL ANNOUNCES CHANGE IN AUDITOR

Titan Medical Inc. has changed its auditor from BDO Canada LLP to MNP LLP, effective Oct. 10, 2023. At the request of the Company, the Former Auditor resigned as auditor of the Company on October 10, 2023 and the board of directors of the Company appointed the Successor Auditor as the new auditor until the next annual general meeting of shareholders of the Company.

The Company confirms that there have been no reservations or modified opinions in the Former Auditor's reports for the two most recently completed financial years or for any period subsequent to the most recently completed period for which an audit report was issued. The Company's board of directors and audit committee each approved the resignation of the Former Auditor and the appointment of the Successor Auditor in place of the Former Auditor; there were no "reportable events", as the term is defined in National Instrument 51-102 - Continuous Disclosure Obligations ("NI 51-102"), in connection with each of the Former Auditor's audits of the Company which occurred prior to their resignation as auditors of the Company; and the Notice of Change of Auditor was approved by the Company's board of directors.

In accordance with NI 51-102, the Notice of Change of Auditor, together with the required letters from the Former Auditor and the Successor Auditor, have been reviewed by the audit committee and the board of directors and have been filed on SEDAR+.

About Titan Medical

Titan Medical Inc. (TSX: TMD; OTC: TMDIF), a medical technology company headquartered in Toronto, Ontario, has developed an expansive patent portfolio related to the enhancement of robotic assisted surgery (RAS), including through a single access point, and is currently focused on evaluating new opportunities to further develop and license its intellectual property.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.